Cardiopulmonary exercise test in chronic heart failure: Beyond peak oxygen consumption

被引：9

作者：

Franco V. ^{[1
]}

机构：

[1] Division of Cardiovascular Disease, DHLRI 200, Section of Advanced Heart Failure and Transplantation, Section of Pulmonary Hypertension, The Ohio State University, 473 West 12th Avenue, Columbus, 43210, OH

来源：

Current Heart Failure Reports | 2011年 / 8卷 / 1期

关键词：

Cardiopulmonary exercise test; Exercise; Exercise test; Functional capacity; Heart failure; Oxygen consumption; RER; Risk stratification; Stress test; Ventilatory efficiency;

D O I：

10.1007/s11897-010-0042-4

中图分类号：

学科分类号：

摘要：

Patients with cardiovascular diseases commonly present with exercise intolerance, clinically manifest as shortness of breath and fatigue, and these symptoms have important prognostic implications. Cardiopulmonary exercise testing is a well-established method for evaluation of cardiopulmonary diseases. It provides an objective assessment of maximal aerobic capacity (peak VO 2), estimates prognosis, and allows the physician to discriminate among many subtle and often overlapping etiologies. This review focuses on the evaluation of important exercise parameters, in addition to the peak VO 2, during cardiopulmonary exercise testing. © 2010 Springer Science+Business Media, LLC.

引用

页码：45 / 50

页数：5

共 35 条

[1]

Mancini D.M., Rahko P.S., Silver M.A., Et al., 2009 Focused Update: ACCF/AHA guidelines for the Diagnosis and Management of Heart Failure in Adults, Circulation, 119, pp. 1977-2016, (2009)

[2]

Ansari M., Massie B.M., Heart failure: How big is the problem? Who are the patients? What does the future hold?, American Heart Journal, 146, 1, pp. 1-4, (2003)

[3]

Guidelines for cardiopulmonary exercise testing, Am J Respir Care Med, 167, pp. 211-277, (2003)

[4]

Balady G.J., Arena R., Sietsema K., Et al., Clinician's guide to cardiopulmonary exercise testing in adults. A scientific statement from the American Heart Association, Circulation, 122, pp. 191-225, (2010)

[5]

Arena R., Myers J., Williams M.A., Gulati M., Kligfield P., Balady G.J., Collins E., Fletcher G., Assessment of functional capacity in clinical and research settings: A scientific statement from the American Heart Association committee on exercise, rehabilitation, and prevention of the council on clinical cardiology and the council on cardiovascular nursing, Circulation, 116, 3, pp. 329-343, (2007)

[6]

Sue D.Y., Hansen J.E., Normal values in adults during exercise training, Clin Chest Med, 5, pp. 89-98, (1984)

[7]

Mancini D.M., Eisen H., Kussmaul W., Et al., Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure, Circulation, 83, pp. 778-786, (1991)

[8]

Lund L.H., Aaronson K.D., Mancini D.M., Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure, American Journal of Cardiology, 95, 6, pp. 734-741, (2005)

[9]

Gibbons R.J., Balady G.J., Bricker J.T., Et al., ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article, Circulation., 106, (2002)

[10]

Swedberg K., Olsson L.G., Charlesworth A., Cleland J., Hanrath P., Komajda M., Metra M., Torp-Pedersen C., Poole-Wilson P., Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: Results from COMET, European Heart Journal, 26, 13, pp. 1303-1308, (2005)

← 1 2 3 4 →